Blackstone Credit
Blackstone Credit is a privately owned hedge fund sponsor based in New York, with additional offices in Los Angeles, Houston, and London. The firm provides investment services to a diverse range of clients, including pooled investment vehicles, corporations, insurance companies, banks, pension funds, endowments, foundations, family offices, and fund of funds. Blackstone Credit primarily invests in the alternative investment markets in the United States, focusing on both public and private securities. Its investment strategies encompass leveraged loans, distressed investments, special situations, capital structure arbitrage, and mezzanine securities. The firm is particularly interested in senior secured loans, corporate bonds, subordinated debt, and equity interests in middle-market private companies, while avoiding significant investments in start-ups or speculative business ventures. Blackstone Credit seeks opportunities across various sectors, including consumer services, energy, technology, healthcare, and real estate, with a preference for private companies within the U.S. It may also explore investments in non-U.S. securities as permitted.
Private Equity Round in 2024
Pine Gate Renewables is a developer and owner-operator of utility-scale solar and energy storage projects in North America. The company has one of the largest operational fleets and development pipelines in the industry, delivering renewable energy solutions to utility and commercial and industrial partners. Pine Gate Renewables specializes in operating utility-scale solar farms and provides a range of related services, including land origination, project development management, community outreach, financing, and asset management. By focusing on these areas, the company aims to supply clean energy to local communities and contribute to the transition toward sustainable energy sources.
Ixcys specializes in providing personalized multichannel services aimed at helping clients digitize their businesses. The company offers a range of services that include the research and implementation of business software, ERP systems, mobile applications, and content management system websites. Additionally, Ixcys provides consultancy services to support clients in developing effective digital communication strategies and enhancing their information technology capabilities. By integrating various information technologies, Ixcys focuses on creating and applying tailored online development strategies and connected management systems to meet the unique needs of its clients.
Amicus Therapeutics is a biotechnology company dedicated to discovering, developing, and commercializing therapies for rare and orphan diseases. The company is known for its product Galafold, an orally administered small molecule pharmacological chaperone specifically designed for treating Fabry disease. Amicus is also advancing its clinical pipeline, including a Phase 3 study of AT-GAA for Pompe disease. The company focuses on creating novel therapies, particularly pharmacological chaperones, which are intended to stabilize and enhance the activity of misfolded enzymes in patients. This approach may improve treatment outcomes, especially when used in conjunction with enzyme replacement therapy. Amicus Therapeutics was founded in 2002 and is headquartered in Cranbury, New Jersey, collaborating with institutions like Nationwide Children's Hospital and the University of Pennsylvania to further its research and development efforts.
Elba Liquefaction Company, based in Savannah, Georgia, is a subsidiary of Kinder Morgan that operates the Elba Liquefaction Project. This facility features 10 small-scale liquefaction units capable of producing approximately 2.5 million tonnes of liquefied natural gas (LNG) per year, which translates to about 350 million cubic feet of natural gas per day. Located 8.5 miles upstream from the mouth of the Savannah River, the project plays a significant role in the liquefaction and export of natural gas. Elba Liquefaction Company was incorporated in 2013 and continues to contribute to the energy sector through its liquefaction operations.
Private Equity Round in 2022
ION Solar is a premium, full-service solar provider. ION's in-house professionals handle the solar process from start to finish giving homeowners a carefree switch to solar. A premium experience shouldn't have to cost more. Pay nothing out of pocket and pay less for power with ION Solar.
Alnylam Pharmaceuticals is a biopharmaceutical company that specializes in the discovery, development, and commercialization of RNA interference (RNAi) therapeutics. The company focuses on addressing rare genetic disorders and diseases affecting the cardiovascular, hepatic, and central nervous systems. Its marketed products include ONPATTRO, which treats hereditary transthyretin-mediated amyloidosis, and GIVLAARI, aimed at adults with acute hepatic porphyria. Additionally, Alnylam is advancing several investigational therapies, such as givosiran for acute hepatic porphyria, lumasiran for primary hyperoxaluria type 1, and vutrisiran for transthyretin amyloidosis. The company has established strategic alliances with organizations such as Sanofi Genzyme and Regeneron Pharmaceuticals to further its RNAi therapeutic developments. Founded in 2002 and headquartered in Cambridge, Massachusetts, Alnylam Pharmaceuticals is recognized as a leader in the RNAi therapeutic field, leveraging Nobel Prize-winning science to create innovative medicines for severe diseases.
Private Equity Round in 2019
SolAero Technologies Corp. is a prominent manufacturer of highly efficient solar cells and solar panels specifically designed for space power applications. Established in 2001, the company has successfully powered 160 space missions without any on-orbit failures, showcasing its commitment to reliability and excellence. SolAero's product offerings include radiation hard solar cells and Coverglass Interconnected Cells (CICs), serving various applications in civil space exploration, scientific research, and defense intelligence. With a focus on precision aerospace structures and solar power systems, SolAero has positioned itself as a leading supplier for demanding space programs across the globe.
Angiotech is a Vancouver, British Columbia pharmaceutical company. Its products enhance the performance of medical devices and biomaterials through the use of pharmacotherapeutics. Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury.
The Omega Group they provide families with good relationships, child care, and advice. They provide education and more, etc.
Private Equity Round in 2014
Sunnova Energy Corporation, based in Houston, Texas, is a provider of residential solar and battery storage services in the United States. Incorporated in 2012, the company serves approximately 63,000 residential customers through a network of local installation partners. Sunnova offers a range of services, including operations and maintenance, monitoring, repairs, equipment upgrades, and onsite power optimization, ensuring reliable energy solutions for homeowners. The company facilitates access to solar energy across more states than any other provider in the nation, allowing homeowners to benefit from worry-free electricity through solar service agreements. By partnering with experienced, locally-owned contractors, Sunnova not only serves its customers effectively but also supports the local economy.
XLN is a telecommunications provider based in London, UK, specializing in utility services for small and medium-sized enterprises. Founded in 2000, the company offers a range of services including broadband and phone line rental, card processing, business energy, mobile services, and online security solutions. In addition, XLN provides tools for checking broadband speed and protecting businesses from malware and other internet threats. The company serves various sectors and industries, focusing on delivering essential services that support the operational needs of its clients.
Private Equity Round in 2014
Lobo Leasing is a Dublin, Ireland based helicopter leasing company serving the global helicopter industry. Lobo Leasing is managed by a seasoned team of helicopter professionals with extensive experience in the commercial helicopter industry. Lobo Leasing is focused on assisting helicopter operators throughout the world on acquiring aircraft through innovative leasing arrangements
LocalVox Media is a marketing platform designed for local businesses, franchises, and multi-location brands, focusing on local, social, and mobile marketing solutions. The platform simplifies the process of online marketing by allowing businesses to manage their presence across various channels, including publishers, social media, search engines, mobile, email newsletters, and their own websites, all through a single interface. LocalVox aims to empower local merchants by providing them with control over their branding and marketing efforts in an increasingly complex online landscape. The company has garnered recognition for its innovative solutions, serving a diverse clientele that ranges from well-known brands to individual service providers. By facilitating effective customer engagement and maximizing the potential of internet marketing, LocalVox enables businesses to concentrate on their core operations while enhancing their online visibility and success.
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases. All projects encompass fundamental research, preclinical studies and clinical trials. Backed by leading venture capital investors, such as Seventure Partners (with the microbiome dedicated vehicle Health for Life Capital) and Family Offices, the company cultivates worldwide collaborations with renowned medical experts to ensure the highest level of standards in the development of innovative drugs. With a total of € 16.5 million raised so far including € 1.5 million grants from French BPI and Aquitaine Region, LNC Therapeutics will pursue its research programs to bring the next generation approach to treat obesity and cardiometabolic diseases.
Private Equity Round in 2011
EMI Music Publishing is a multinational music publishing company that specializes in the publishing and licensing of music across various media. The company manages a diverse catalog of music, which includes works used in advertising, film, television, and video games. Additionally, EMI Music Publishing engages in licensing music for merchandising and other related businesses, playing a significant role in the music industry by facilitating access to its extensive repertoire for various commercial purposes.
Stolle Machinery is a manufacturer and supplier of can making machinery, primarily serving the commercial and industrial sectors. The company produces equipment for the fabrication of aluminum and steel beverage and food cans, focusing on two-piece beverage can production. In addition to its core machinery offerings, Stolle Machinery provides tooling, spare parts, and aftermarket services. The company also develops inside spray systems and light testers specifically designed for beverage and food cans. Furthermore, Stolle Machinery supports the printing industry with a range of narrow web offset presses and packaging solutions, enhancing its product portfolio and service capabilities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.